Tin tức & Cập nhật

Evidence supports semaglutide for obesity-related HFpEF

Semaglutide improves exercise function in patients with obesity-related heart failure with preserved ejection fraction (HFpEF) in a secondary analysis of the prespecified pooled STEP-HFpEF and STEP-HFpEF DM trials presented at HFSA 2024.

Morning tiredness, insomnia tied to BP elevation among postmenopausal women

Postmenopausal women with elevated levels of evening blood pressure (BP) appear to experience morning tiredness and insomnia, as reported in a study.

Cumulative pulse pressure load tied to all-cause death in older adults

Long-term exposure to elevated cumulative pulse pressure (cPP) potentially increases the risk of all-cause deaths, while prolonged exposure to elevated cumulative systolic blood pressure (cSBP) contributes to a higher risk of cardiovascular death, suggests a study.

CVD risk remain high despite successful treatment for depression

A recent study suggests that successful treatment of depression alone is not enough to protect patients against the associated risk of cardiovascular disease (CVD).

VIATRIS MASTERCLASS 2024 - EMERGING ASIA MEDICAL AFFAIRS (August 3rd & 4th, 2024 | Da Nang, Vietnam)

Hyperuricaemia linked to short-term readmission, mortality risk in HF

For patients with heart failure (HF), hyperuricaemia is a risk factor for an increase in the risk of short-term hospital readmission and mortality, as reported in a retrospective study.

Mitral TEER clips hold benefits at 1 year in patients with atrial SMR

An analysis of the EXPANDed patient-level pooled cohort presented at HFSA 2024 demonstrates clinical benefits in patients with atrial SMR at 1 year following a mitral TEER procedure using newer-generation clip devices. These included a significant reduction in MR and substantial improvements in PROs

Tailored peritoneal dialysis training program cuts infection, dropout rates

A Singapore hospital has pioneered a tailored peritoneal dialysis (PD) training program that has yielded a significant reduction in PD-related infections and dropouts among patients with end-stage kidney disease (ESKD).